SIGNATUREFD, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,214
-3.5%
443
+5.2%
0.00%
Q2 2023$12,655
-22.9%
421
-7.1%
0.00%
Q1 2023$16,412
+1.1%
453
-0.4%
0.00%
Q4 2022$16,230
+8.2%
4550.0%0.00%
-100.0%
Q3 2022$15,000
+66.7%
455
+54.2%
0.00%
Q2 2022$9,0000.0%295
+1.4%
0.00%
Q1 2022$9,000
+12.5%
2910.0%0.00%
Q4 2021$8,0000.0%2910.0%0.00%
Q3 2021$8,000
-11.1%
2910.0%0.00%
Q2 2021$9,000
+12.5%
2910.0%0.00%
Q1 2021$8,000
+14.3%
2910.0%0.00%
Q4 2020$7,0000.0%291
-10.5%
0.00%
Q3 2020$7,000
+133.3%
325
+155.9%
0.00%
Q2 2020$3,000127
+568.4%
0.00%
Q4 2019$0
-100.0%
190.0%0.00%
Q3 2019$1,0000.0%190.0%0.00%
Q2 2019$1,0000.0%190.0%0.00%
Q1 2019$1,0000.0%190.0%0.00%
Q4 2018$1,0000.0%190.0%0.00%
Q3 2018$1,0000.0%190.0%0.00%
Q2 2018$1,0000.0%190.0%0.00%
Q1 2018$1,000190.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders